A new analysis from the CorEvitas Psoriasis Registry highlights baseline clinical and patient-reported features associated with switching biologic therapies in real-world practice, offering insights to support earlier, shared decision-making.
A new analysis from the CorEvitas Psoriasis Registry highlights baseline clinical and patient-reported features associated with switching biologic therapies in real-world practice, offering insights to support earlier, shared decision-making.
A new analysis from the...